Manufacturing robotics investment to boost UK pharma output by 10%

Investing an additional £1.2 billion into the manufacturing robotics processes could add as much as £60.5 billion to the UK economy over the next decade, according to research from Barclays more »

Nov 30, 2015 11:22 AM News

Almirall acquires rights to two dermatology drugs

Almirall has acquired the rights to Veltin and Altabax, from Stiefel, a GSK company, in exchange for distribution rights to Toctino and an undisclosed cash payment more »

Nov 30, 2015 10:47 AM News

AstraZeneca and Palago team up on R&D

Pelago Bioscience and AstraZeneca team up for cellular thermal shift assay (CETSA) more »

Nov 27, 2015 3:34 PM News

Novartis' heart failure medicine receives EU approval

The European Commission (EC) has approved Novartis’ Entresto (sacubitril/valsartan) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF) more »

Nov 27, 2015 1:59 PM News

Enrollment completed for acute coronary syndrome drug trial

Sanofi and Regeneron Pharmaceuticals have completed enrollment in the global phase three, Odyssey Outcomes trial for patients suffering from acute coronary syndrome (ACS) more »

Nov 27, 2015 11:12 AM News

Big data tool determines side effects of medicine

Data tool will identify side effects of medicines more »

Nov 26, 2015 11:48 AM News

Event: Access to Safe Medicines Europe Forum

The Access to Safe Medicines Europe Forum (ASM Europe) 2016 will take place on 19-20 January 2016 at the Sheraton Skyline, Heathrow, London more »

Nov 25, 2015 4:48 PM News

Collaboration to focus on nanobody drug discovery

Ablynx and Novo Nordisk will collaborate to discover and develop multi-specific nanobody drug candidates with an option to expand the agreement to include a second nanobody programme more »

Nov 25, 2015 12:20 PM News

Turning the tables: company that increased HIV drug price by 5000% suffers £9.7 m net loss

Turing Pharmaceuticals posted a £9.7 million ($14.6m) net loss in the third quarter of 2015 and is now set to reduce the cost of Daraprim by 50% according to the company and The Wall Street Journal more »

Nov 24, 2015 4:12 PM News

Catalent expands its biologics capabilities

Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics more »

Nov 24, 2015 12:22 PM News

Concert Pharma achieves $2m milestone for Alzheimer’s drug

Concert Pharmaceuticals has achieved a $2 million (£1.3m) milestone under its development and license agreement with Avanir Pharmaceuticals for the phase three initiation of AVP-786 for agitation in patients with Alzheimer’s more »

Nov 24, 2015 10:33 AM News

Topas offers alternative to barex for medical packaging

Topas cyclic olefin copolymer (COC) from Topas Advanced Polymers has been identified as a suitable alternative to barex polyacrylonitrile (PAN) more »

Nov 23, 2015 4:50 PM News

ObsEva and Kissei Pharmaceutical team up for Endometriosis treatment

The two companies will collaborate to develop and commercialise KLH-2109 for the treatment of Endometriosis more »

Nov 23, 2015 3:16 PM News

Rob Wilson / Shutterstock.com

Pfizer seals tax-friendly deal with Allergan

Big pharma player Pfizer has inked its long-rumoured deal to buy botox maker Allergan, in what the BBC describes as “the biggest pharmaceuticals deal in history” more »

Nov 23, 2015 2:54 PM News

Drugs discovery extends lifetimes for skin cancer patients

Study reveals drugs that can extend the lives of patients with skin cancer more »

Nov 23, 2015 9:59 AM News

How to build quality in the freeze drying process

Biopharma Technology explains how to build quality in the lyophilisation processes more »

Nov 20, 2015 3:24 PM Opinion

Camfil APC
CPC Whitepaper
Medical Expo

No events

Built with Metro Publisher™